Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Glucagon and type 2 diabetes: the return of the alpha cell
Asger Lund
,
Jonatan I Bagger
,
Mikkel Christensen
, Filip K Knop,
Tina Vilsbøll
Department of Clinical Pharmacology
114
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucagon and type 2 diabetes: the return of the alpha cell'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alpha Cell
100%
Antagonization
33%
B Cells
33%
Effective Treatment
33%
Gastrointestinal Hormones
33%
Glucagon
100%
Glucagon Receptor
66%
Glucagon Secretion
100%
Glucagon-like
33%
Glucose Homeostasis
33%
Glucose-dependent Insulinotropic Polypeptide
66%
Hepatic Glucose Production
66%
Hyperglucagonemia
66%
Hyperglycemia
33%
Incretin Hormones
33%
Insulin
33%
Normal Physiology
33%
Pancreatic Islet Cells
33%
Pathophysiology
33%
Regulatory Effect
33%
Treatment Strategy
33%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic
33%
Type 2 Diabetic Patients
100%
Medicine and Dentistry
Beta Cell
33%
Clinical Study
33%
Diabetes Mellitus
33%
Gastric Inhibitory Polypeptide
66%
Gastrointestinal Hormone
33%
Glucagon
100%
Glucagon Like Peptide 1
33%
Glucagon Receptor
66%
Glucagon Release
100%
Gluconeogenesis
66%
Glucose Homeostasis
33%
Hyperglucagonemia
66%
Hyperglycemia
33%
Incretin
33%
Maturity Onset Diabetes of the Young
100%
Pathophysiology
33%
Patient with Type 2 Diabetes
100%
Biochemistry, Genetics and Molecular Biology
Clinical Study
33%
Gastric Inhibitory Polypeptide
66%
Gastrointestinal Hormone
33%
Glucagon
100%
Glucagon Receptor
66%
Glucagon Release
100%
Glucagon-Like Peptide-1
33%
Gluconeogenesis
66%
Glucose Homeostasis
33%
Hyperglycemia
33%
Incretin
33%